MYSE · Myseum, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Revenue | $550 | $436 | $672 | $46.2K | $4.4K |
| Cost of Revenue | - | - | - | - | - |
| Gross Profit | - | - | - | - | - |
| R&D | $166.7K | $857.7K | $1.35M | $515.0K | - |
| SG&A | $730.2K | $943.0K | $893.0K | $991.9K | $106.3K |
| Total Operating Expenses | $5.49M | $5.28M | $12.27M | $12.27M | $1.08M |
| D&A | $41.4K | $23.1K | $127.5K | $127.5K | $2.3K |
| Operating Income | ($5.49M) | ($5.28M) | ($8.78M) | ($10.84M) | - |
| Interest Expense | $752 | - | - | - | $45.5K |
| Income Tax | - | - | - | - | - |
| Net Income | ($2.61M) | ($4.24M) | ($8.40M) | ($12.14M) | ($979.5K) |
| EPS - Basic | ($0.62) | ($1.43) | ($4.14) | ($7.10) | - |
| EPS - Diluted | ($0.62) | ($1.43) | ($4.14) | ($7.10) | - |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | $749.0K | $1.20M | $953.4K | $1.73M | $70.8K |
| Accounts Receivable | $83 | $207 | $183 | $384 | $278 |
| Inventory | - | - | - | - | - |
| Accounts Payable | - | - | - | - | - |
| Current Assets | $3.97M | $4.29M | $6.38M | $12.88M | $20.58M |
| Total Assets | $7.20M | $5.37M | $6.51M | $13.11M | $20.82M |
| Current Liabilities | $924.8K | $630.3K | $406.6K | $473.4K | $580.0K |
| Long-term Debt | - | - | - | - | - |
| Total Liabilities | $1.09M | $630.3K | $406.6K | $557.1K | $731.0K |
| Stockholders' Equity | $6.10M | $6.88M | $6.10M | $12.56M | $20.08M |
| Retained Earnings | ($54.98M) | ($52.37M) | ($48.13M) | ($39.73M) | ($27.59M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Operating Cash Flow | ($4.27M) | ($4.39M) | ($6.53M) | ($7.26M) | ($1.10M) |
| Investing Cash Flow | ($244.2K) | $2.24M | $6.16M | ($11.21M) | ($56.0K) |
| Financing Cash Flow | $4.49M | $2.39M | ($398.3K) | $1.1K | $1.72M |
| CapEx | $4.5K | - | $49.5K | $44.5K | $56.0K |
| Free Cash Flow | ($4.27M) | - | ($6.58M) | ($7.30M) | ($1.15M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | - | - | - | - | - |
| Operating margin | -998192.4% | -1211216.3% | -1307147.5% | -23453.0% | - |
| EBITDA margin | -990659.6% | -1205911.5% | -1288174.1% | -23177.1% | - |
| Net margin | -474049.5% | -972284.4% | -1250739.6% | -26266.0% | -22035.3% |
| Free cash flow margin | -776645.3% | - | -978982.4% | -15803.1% | -25908.1% |
| FCF / Net income | 1.64 | - | 0.78 | 0.60 | 1.18 |
| R&D / Revenue | 30303.1% | 196712.8% | 201103.4% | 1114.3% | - |
| SG&A / Revenue | 132762.0% | 216282.1% | 132882.7% | 2146.3% | 2391.5% |
| Effective tax rate | - | - | - | - | - |
| Return on assets | -36.2% | -78.9% | -129.2% | -92.6% | -4.7% |
| Return on equity | -42.7% | -61.6% | -137.8% | -96.7% | -4.9% |
| Return on invested capital | - | - | - | - | - |
| Liquidity | |||||
| Current ratio | 4.29 | 6.80 | 15.68 | 27.20 | 35.48 |
| Quick ratio | 4.29 | 6.80 | 15.68 | 27.20 | 35.48 |
| Cash ratio | 0.81 | 1.90 | 2.34 | 3.66 | 0.12 |
| Leverage | |||||
| Debt / Equity | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - |
| Interest coverage | -7300.6x | - | - | - | - |
| Equity multiplier | 1.18 | 0.78 | 1.07 | 1.04 | 1.04 |
| Liabilities / Assets | 0.15 | 0.12 | 0.06 | 0.04 | 0.04 |
| Efficiency | |||||
| Asset turnover | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Inventory turnover | - | - | - | - | - |
| Days sales outstanding | 55d | 173d | 99d | 3d | 23d |
| Days inventory outstanding | - | - | - | - | - |
| Days payable outstanding | - | - | - | - | - |
| Cash conversion cycle | - | - | - | - | - |
| Valuation | |||||
| P / E | - | - | - | - | - |
| P / B | 1.2x | 0.8x | 1.0x | 3.0x | - |
| P / S | 13048.1x | 12079.6x | 8663.7x | 819.6x | - |
| EV / EBITDA | - | - | - | - | - |
| Growth | |||||
| Revenue growth (YoY) | 26.1% | -35.1% | -98.5% | 939.7% | - |
| Revenue CAGR (3y) | -77.2% | -53.9% | - | - | - |
| Revenue CAGR (5y) | - | - | - | - | - |
| Gross profit growth (YoY) | - | - | - | - | - |
| Operating income growth (YoY) | -4.0% | 39.9% | 19.0% | - | - |
| Net income growth (YoY) | 38.5% | 49.6% | 30.8% | -1139.3% | - |
| EPS growth (YoY) | 56.6% | 65.5% | 41.7% | - | - |
| EPS CAGR (3y) | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - |
| FCF growth (YoY) | - | - | 9.9% | -534.2% | - |
| FCF CAGR (5y) | - | - | - | - | - |
| Book value growth (YoY) | -11.3% | 12.8% | -51.4% | -37.5% | - |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2023-12-31.
Product / service
$672 totalSubscription Revenues$672 · 100.0%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
-6.19
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
1/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Telegraph & Other Message Communications
Comparing Myseum against the 5 most active filers in the same SIC group.